150 related articles for article (PubMed ID: 30649660)
1. Macrophage phenotype bioengineered by magnetic, genetic, or pharmacologic interference.
Wosik J; Suarez-Villagran M; Miller JH; Ghobrial RM; Kloc M
Immunol Res; 2019 Feb; 67(1):1-11. PubMed ID: 30649660
[TBL] [Abstract][Full Text] [Related]
2. Mouse macrophage polarity and ROCK1 activity depend on RhoA and non-apoptotic Caspase 3.
Liu Y; Minze LJ; Mumma L; Li XC; Ghobrial RM; Kloc M
Exp Cell Res; 2016 Feb; 341(2):225-36. PubMed ID: 26875770
[TBL] [Abstract][Full Text] [Related]
3. RhoA Pathway and Actin Regulation of the Golgi/Centriole Complex.
Kloc M; Uosef A; Wosik J; Kubiak JZ; Ghobrial RM
Results Probl Cell Differ; 2019; 67():81-93. PubMed ID: 31435793
[TBL] [Abstract][Full Text] [Related]
4. Macrophages and RhoA Pathway in Transplanted Organs.
Liu Y; Kubiak JZ; Li XC; Ghobrial RM; Kloc M
Results Probl Cell Differ; 2017; 62():365-376. PubMed ID: 28455717
[TBL] [Abstract][Full Text] [Related]
5. Dissonant response of M0/M2 and M1 bone-marrow-derived macrophages to RhoA pathway interference.
Liu Y; Chen W; Minze LJ; Kubiak JZ; Li XC; Ghobrial RM; Kloc M
Cell Tissue Res; 2016 Dec; 366(3):707-720. PubMed ID: 27628094
[TBL] [Abstract][Full Text] [Related]
6. Magnetic Field Changes Macrophage Phenotype.
Wosik J; Chen W; Qin K; Ghobrial RM; Kubiak JZ; Kloc M
Biophys J; 2018 Apr; 114(8):2001-2013. PubMed ID: 29694876
[TBL] [Abstract][Full Text] [Related]
7. Screening RhoA/ROCK inhibitors for the ability to prevent chronic rejection of mouse cardiac allografts.
Chen W; Chen S; Chen W; Li XC; Ghobrial RM; Kloc M
Transpl Immunol; 2018 Oct; 50():15-25. PubMed ID: 29885441
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of RhoA and mTORC2/Rictor by Fingolimod (FTY720) induces p21-activated kinase 1, PAK-1 and amplifies podosomes in mouse peritoneal macrophages.
Chen W; Ghobrial RM; Li XC; Kloc M
Immunobiology; 2018 Nov; 223(11):634-647. PubMed ID: 30005970
[TBL] [Abstract][Full Text] [Related]
9. Macrophage/monocyte-specific deletion of Ras homolog gene family member A (RhoA) downregulates fractalkine receptor and inhibits chronic rejection of mouse cardiac allografts.
Liu Y; Chen W; Wu C; Minze LJ; Kubiak JZ; Li XC; Kloc M; Ghobrial RM
J Heart Lung Transplant; 2017 Mar; 36(3):340-354. PubMed ID: 27692539
[TBL] [Abstract][Full Text] [Related]
10. ROCK inhibition impedes macrophage polarity and functions.
Liu Y; Tejpal N; You J; Li XC; Ghobrial RM; Kloc M
Cell Immunol; 2016 Feb; 300():54-62. PubMed ID: 26711331
[TBL] [Abstract][Full Text] [Related]
11. FilGAP and its close relatives: a mediator of Rho-Rac antagonism that regulates cell morphology and migration.
Nakamura F
Biochem J; 2013 Jul; 453(1):17-25. PubMed ID: 23763313
[TBL] [Abstract][Full Text] [Related]
12. MDA-9/Syntenin (SDCBP) modulates small GTPases RhoA and Cdc42 via transforming growth factor β1 to enhance epithelial-mesenchymal transition in breast cancer.
Menezes ME; Shen XN; Das SK; Emdad L; Sarkar D; Fisher PB
Oncotarget; 2016 Dec; 7(49):80175-80189. PubMed ID: 27863394
[TBL] [Abstract][Full Text] [Related]
13. BART inhibits pancreatic cancer cell invasion by inhibiting ARL2-mediated RhoA inactivation.
Taniuchi K; Iwasaki S; Saibara T
Int J Oncol; 2011 Nov; 39(5):1243-52. PubMed ID: 21833473
[TBL] [Abstract][Full Text] [Related]
14. Simvastatin enhances Rho/actin/cell rigidity pathway contributing to mesenchymal stem cells' osteogenic differentiation.
Tai IC; Wang YH; Chen CH; Chuang SC; Chang JK; Ho ML
Int J Nanomedicine; 2015; 10():5881-94. PubMed ID: 26451103
[TBL] [Abstract][Full Text] [Related]
15. Simulated Microgravity Promotes Angiogenesis through RhoA-Dependent Rearrangement of the Actin Cytoskeleton.
Shi F; Wang YC; Hu ZB; Xu HY; Sun J; Gao Y; Li XT; Yang CB; Xie C; Li CF; Zhang S; Zhao JD; Cao XS; Sun XQ
Cell Physiol Biochem; 2017; 41(1):227-238. PubMed ID: 28214845
[TBL] [Abstract][Full Text] [Related]
16. KIF17 regulates RhoA-dependent actin remodeling at epithelial cell-cell adhesions.
Acharya BR; Espenel C; Libanje F; Raingeaud J; Morgan J; Jaulin F; Kreitzer G
J Cell Sci; 2016 Mar; 129(5):957-70. PubMed ID: 26759174
[TBL] [Abstract][Full Text] [Related]
17. FAM13A is a modifier gene of cystic fibrosis lung phenotype regulating rhoa activity, actin cytoskeleton dynamics and epithelial-mesenchymal transition.
Corvol H; Rousselet N; Thompson KE; Berdah L; Cottin G; Foussigniere T; Longchampt E; Fiette L; Sage E; Prunier C; Drumm M; Hodges CA; Boëlle PY; Guillot L
J Cyst Fibros; 2018 Mar; 17(2):190-203. PubMed ID: 29239766
[TBL] [Abstract][Full Text] [Related]
18. Piezo2 channel regulates RhoA and actin cytoskeleton to promote cell mechanobiological responses.
Pardo-Pastor C; Rubio-Moscardo F; Vogel-González M; Serra SA; Afthinos A; Mrkonjic S; Destaing O; Abenza JF; Fernández-Fernández JM; Trepat X; Albiges-Rizo C; Konstantopoulos K; Valverde MA
Proc Natl Acad Sci U S A; 2018 Feb; 115(8):1925-1930. PubMed ID: 29432180
[TBL] [Abstract][Full Text] [Related]
19. DEF6, a novel PH-DH-like domain protein, is an upstream activator of the Rho GTPases Rac1, Cdc42, and RhoA.
Mavrakis KJ; McKinlay KJ; Jones P; Sablitzky F
Exp Cell Res; 2004 Apr; 294(2):335-44. PubMed ID: 15023524
[TBL] [Abstract][Full Text] [Related]
20. Simvastatin Attenuates Neuropathic Pain by Inhibiting the RhoA/LIMK/Cofilin Pathway.
Qiu Y; Chen WY; Wang ZY; Liu F; Wei M; Ma C; Huang YG
Neurochem Res; 2016 Sep; 41(9):2457-69. PubMed ID: 27216618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
